BI
AGN

Boulegeris Investments’s Allergan plc AGN Stock Holding History

Boulegeris Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-26,842
Closed -$4.47M – 54
2018
Q2 		$4.47M Buy
26,842
+798
+3% +$128K 2.24% 10
2018
Q1 		$4.38M Buy
26,044
+30
+0.1% +$5.03K 2.4% 8
2017
Q4 		$4.25M Sell
26,014
-8,052
-24% -$1.44M 2.21% 8
2017
Q3 		$6.98M Buy
34,066
+461
+1% +$107K 3.88% 7
2017
Q2 		$8.17M Buy
33,605
+2,125
+7% +$499K 4.61% 6
2017
Q1 		$7.52M Buy
31,480
+261
+0.8% +$60.8K 4.5% 7
2016
Q4 		$6.56M Buy
31,219
+2,060
+7% +$427K 3.99% 6
2016
Q3 		$6.72M Buy
29,159
+2,350
+9% +$574K 4.25% 6
2016
Q2 		$6.2M Buy
26,809
+3,609
+16% +$832K 4.22% 7
2016
Q1 		$6.22M Buy
23,200
+35
+0.2% +$10K 4.38% 9
2015
Q4 		$7.24M Buy
23,165
+650
+3% +$194K 5.25% 7
2015
Q3 		$6.12M Buy
22,515
+3,680
+20% +$1.13M 4.68% 9
2015
Q2 		$5.72M Buy
18,835
+4,949
+36% +$1.48M 4.1% 10
2015
Q1 		$4.13M Buy
+13,886
New +$3.96M 3.04% 13

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Boulegeris Investments's AGN Position: Q3 2018 in Review

Boulegeris Investments sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 26,842 shares — an estimated $4.47M sold.

Boulegeris Investments first reported a position in AGN in Q1 2015 and held it in 14 quarters. The position peaked at $8.17M in Q2 2017. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Boulegeris Investments reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Boulegeris Investments sold 26,842 Allergan plc shares in Q3 2018, an estimated $4.47M.
  • Boulegeris Investments first reported a position in Allergan plc in Q1 2015 and held it in 14 quarters.
  • Boulegeris Investments's Allergan plc position peaked at $8.17M in Q2 2017.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Boulegeris Investments's 13F filing for Q3 2018.